...
首页> 外文期刊>BMC Cancer >Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
【24h】

Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis

机译:老年鼻咽癌患者的诱导化学疗法后放疗与同期放化疗:从倾向匹配分析中发现

获取原文
           

摘要

Background To date, no guideline is proposed for elderly nasopharyngeal carcinoma (NPC) due to lack of prospective clinical trials. The present study comparing the survivals and toxicities in elderly NPC patients received either induction chemotherapy followed by radiotherapy(IC?+?RT) or concurrent chemoradiotherapy (CCRT) was therefore undertaken to provide a more accurate basis for future clinical practice. Methods The eligible elderly NPC patients were retrospectively enrolled. Propensity score matching generated a matched cohort (1:2) composed from CCRT and IC?+?RT groups. The survivals and treatment-induced toxicities were compared between two groups. Multivariable analysis was carried to identify significant prognostic factors. Results The 5-year overall survival, cancer-specific survival, locoregional failure-free survival, distant failure-free survival for all patients were 58.3?%, 62.7?%, 88.7?%, 83.0?%, respectively. No significant survival differences were found between CCRT and IC?+?RT groups in the propensity-matched cohort. In comparison with the patients who received IC?+?RT, patients who underwent CCRT were associated with more severe acute toxicities including leucopenia (30?% vs. 6.8?%, P =?0.005), anemia (20?% vs. 4.1?%, P =?0.027), mucositis (63.3?% vs. 34.2?%, P =?0.007), weight loss (23.4?% vs. 4.1?%, P =?0.009). Basicranial bone involvement was an independent prognostic factor that predicted all-cause death (HR?=?0.553, 95 % CI 0.329–0.929; P =?0.025) and cancer specific death (HR?=?0.558, 95 % CI 0.321–0.969; P =?0.038) in elderly patients. Conclusions In the context of no guideline for elderly NPC, the present study suggested IC?+?RT should be a preferable modality compared with CCRT, with similar treatment outcomes but less acute toxicities.
机译:背景技术迄今为止,由于缺乏前瞻性临床试验,因此尚未提出针对老年鼻咽癌(NPC)的指南。因此,本研究比较了老年NPC患者在诱导化疗后放疗(IC + RT)或同期放化疗(CCRT)的生存率和毒性,为将来的临床实践提供了更准确的依据。方法对符合条件的老年NPC患者进行回顾性研究。倾向得分匹配产生了由CCRT和IC?+?RT组组成的匹配队列(1:2)。比较两组的存活率和治疗引起的毒性。进行多变量分析以鉴定重要的预后因素。结果所有患者的5年总生存率,癌症特异性生存率,局部无衰竭生存率,远处无衰竭生存率分别为58.3%,62.7%,88.7%,83.0%。在倾向匹配的人群中,CCRT组和ICα+ΔRT组之间没有发现明显的生存差异。与接受IC?+?RT的患者相比,接受CCRT的患者具有更严重的急性毒性,包括白血球减少症(30%vs. 6.8%,P = 0.005),贫血(20 %%与4.1)。 %,P = 0.027%,粘膜炎(63.3%对34.2%,P = 0.007),体重减轻(23.4%对4.1%,P = 0.009)。基本颅骨受累是一个独立的预后因素,可预测全因死亡(HR≥0.553,95%CI 0.329-0.929; P = 0.025)和癌症特异性死亡(HR≥0.558,95%CI 0.321-0.969)。 ; P =?0.038)。结论在没有指导的老年NPC的背景下,本研究表明ICCC +ΔRT应该是CCRT首选的治疗方式,具有相似的治疗效果,但急性毒性较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号